Ten years of the Uruguayan Registry of Peritonitis in Peritoneal Dialysis
Keywords:
PERITONITIS, PERITONEAL DYALISISAbstract
Peritonitis is a severe complication of peritoneal dialysis (PD), so it is important to learn about the incidence and antibiotic sensitivity of the germs that cause it. In Uruguay, since January 1, 2004, a national record is kept for peritonitis in PD, germs, sensitivity and evolution.
Method: the records from January 1, 2004 through December 31, 2013 were analyzed. The registry was approved by institutional ethical committes.
Results: during the above mentioned period, 850 cases of peritonitis were recorded, and incidence dropped from 0.49/patient-year (2004-2005) to 0.37/patient-year (2013). Incidence of Staphylococcus aureus and coagulase-negative staphylococci (SCoN) was lower in 2009-2013 vs 2004-2005 (0.2 vs 0.12 peritonitis/patient-year, test Poisson p<0.05). In 2009-2013: 14/54 S. aureus and 26/71 SCoN were methicillin-resistant, similar to the previous period. 98% of Gram-negative were sensitive to amikacin. No germ was identified in 145/467 (31%) of episodes. Primary cure was achieved in 71% of peritonitis for Gram-positive and 45% for Gram-negative bacteria (chi2 p<0.05). In 2013 a greater incidence of peritonitis was observed in those centers where the nasal carriage was not controlled.
Comments and conclusions: controlling Staphylococcus aureus nasal carriages is worth doing. The incidence of peritonitis by methicillin-resistant S. aureus y SCoN, the sustained incidence of Gram-negative germs (with a worse evolution), and the high percentage of cultures with no development justify keeping the initial empirical antibiotic protocol with vancomycin and amikacin. Reduction in the incidence of S. aureus + SCoN could be explained by a greater education in PD patients.
References
(2) Ballerini L, Paris V. Nosogogy: when the learner is a patient with chronic renal failure. Kidney Int Suppl 2006; (103):S122-6.
(3) Hsieh YP, Wang SC, Chang CC, Wen YK, Chiu PF, Yang Y. The negative impact of early peritonitis on continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2014; 34(6):627-35.
(4) Montenegro J, Correa-Rotter R, Riella M. Tratado de diálisis peritoneal. 2 ed. Barcelona: Elsevier, 2009.
(5) Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25(2):107-31.
(6) Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011; 31(6):614-30.
(7) Barretti P, Doles JV, Pinotti DG, El Dib R. Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis. BMC Infect Dis 2014; 14:445.
(8) Akoh JA. Peritoneal dialysis associated infections: An update on diagnosis and management. World J Nephrol 2012; 1(4):106-22.
(9) Gadola L, Orihuela L, Pérez D, Gómez T, Solá L, Chifflet L, et al. Peritonitis in peritoneal dialysis patients in Uruguay. Perit Dial Int 2008; 28(3):232-5.
(10) Li PK, Chow KM. Infectious complications in dialysis: epidemiology and outcomes. Nat Rev Nephrol 2011; 8(2):77-88.
(11) Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, Cross NB, et al. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev 2014; (4):CD005284.
(12) Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis 2014; 64(2):278-89.
(13) Bajo Rubio MA, Selgas R, Remón C, Arrieta J, Álvarez-Ude F, Arenas MD, et al. Plan de calidad científico-técnica y de mejora continua de la calidad en diálisis peritoneal. Nefrología (Madr.) 2010; 30(1):28-45.
(14) Gadola L, Poggi C, Poggio M, Sáez L, Ferrari A, Romero J, et al. Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients. Perit Dial Int 2013; 33(1):38-45.
(15) Yip T, Tse KC, Lam MF, Cheng SW, Lui SL, Tang S, et al. Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int 2007; 27(5):560-4.
(16) Barretti P, Pereira D, Brasil MA, de Lourdes Cunha M, Caramori J, Montelli A. Evolution of gram-negative bacilli susceptibility in peritoneal dialysis-related peritonitis in Brazil: a single center’s experience over nine years. Perit Dial Int 2009; 29(2):230-3.
(17) Gadola L, Schwedt E, Díaz A, Sola L, Falchi B, Verdaguer C, et al. Informe del Programa de Diálisis Peritoneal Continua Ambulatoria (Uruguay). En: I Congresso Latino Americano de Diálise Peritoneal. Florianópolis, 21-23 de outubro de 1988.
(18) Rodríguez-Carmona A, Pérez-Fontán M, López-Muñiz A, Ferreiro-Hermida T, García-Falcón T. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis. Perit Dial Int 2014; 34(6):618-26.
(19) Szeto CC, Chow KM, Wong TY, Leung CB, Li PK. Influence of climate on the incidence of peritoneal dialysis-related peritonitis. Perit Dial Int 2003; 23(6):580-6.
(20) Stinghen AE, Barretti P, Pecoits-Filho R. Factors contributing to the differences in peritonitis rates between centers and regions. Perit Dial Int 2007; 27(Suppl 2):S281-5.
(21) Núñez-Moral M, Sánchez-Álvarez JE, González-Díaz I, Peláez-Requejo B, Quintana-Fernández A, Rodríguez-Suárez C. Seasonal variations and influence of the weather on the appearance of peritoneal infection. Nefrología 2014; 34(6):743-8.
(22) Cho Y, Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville N, et al. Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study. Nephrol Dial Transplant 2012; 27(5):2028-36.
(23) van Esch S, Krediet R, Struijk DG. Prognostic factors for peritonitis outcome. En: Ronco C, Rosner MH, Crepaldi C, eds. Peritoneal dialysis: state of the art 2012. Basel: Karger 2012. v.178:264-70.
(24) Szeto CC, Chow KM. Gram-negative peritonitis—the Achilles heel of peritoneal dialysis? Perit Dial Int 2007; 27(Suppl 2):S267-71.
(25) Siva B, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 2009; 4(5):957-64.
(26) Szeto CC, Chow VC, Chow KM, Lai RW, Chung KY, Leung CB, et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 2006; 69(7):1245-52.
(27) Muñoz de Bustillo E, Borrás F, Gómez-Roldán C, Pérez-Contreras FJ, Olivares J, García R, et al. Impacto de las peritonitis en la supervivencia a largo plazo de los pacientes en diálisis peritoneal. Nefrología (Madr.) 2011; 31(6):723-32.
(28) de Moraes TP, Olandoski M, Caramori JC, Martin LC, Fernandes N, Divino-Filho JC, et al. Novel predictors of peritonitis-related outcomes in the BRAZPD cohort. Perit Dial Int 2014; 34(2):179-87.
(29) Tsai CC, Lee JJ, Liu TP, Ko WC, Wu CJ, Pan CF, et al. Effects of age and diabetes mellitus on clinical outcomes in patients with peritoneal dialysis-related peritonitis. Surg Infect (Larchmt) 2013; 14(6):540-6.
(30) Kumar VA, Sidell MA, Yang WT, Jones JP. Predictors of peritonitis, hospital days, and technique survival for peritoneal dialysis patients in a managed care setting. Perit Dial Int 2014; 34(2):171-8.
(31) Feneberg R, Warady BA, Alexander SR, Schaefer F; International Pediatric Peritonitis Registry. The international pediatric peritonitis registry: a global Internet-based initiative in pediatric dialysis. Perit Dial Int 2005; 25(Suppl 3):S130-4.
